Company: LIGAND PHARMACEUTICALS INC

Form Type: 8-K

Filing Date: 2024-08-06

Corporate Action: Spin-off

Type: Update

Accession Number: 000088616324000067

Comments: This document does not pertain to a spin-off.

Document Link: View Document

Form Type: 8-K

Filing Date: 2024-07-08

Corporate Action: Spin-off

Type: New

Accession Number: 000088616324000053

Comments: Ligand Pharmaceuticals Incorporated has entered into a stock purchase agreement to invest in invIOs Holding AG, a spin-off of APEIRON Biologics AG. This transaction is expected to close in July 2024.

Document Link: View Document